Scanditronix was omitted in our last issue from a list of vendors(SCAN 7/31/91) that have developed negative-ion cyclotrons--so-calledbaby cyclotrons--for the production of positron emission tomographyradiopharmaceuticals. Negative-ion machines don't
Scanditronix was omitted in our last issue from a list of vendors(SCAN 7/31/91) that have developed negative-ion cyclotrons--so-calledbaby cyclotrons--for the production of positron emission tomographyradiopharmaceuticals.
Negative-ion machines don't produce the radiation that traditionalPET cyclotrons generate, so shielding requirements are reduced.The lower shielding requirement trims manufacturing and sitingcosts, which in turn reduces the overall cost of operating a PETsystem (see story, page one).
GE Medical Systems, which purchased the Scanditronix PET camerabusiness early last year (SCAN 12/13/89), is exclusive distributorof the PETtrace 200 cyclotron, said Dow R. Wilson, GE PET marketingmanager.
With GE marketing the Scanditronix negative-ion system, allthree major PET vendors--Siemens, Positron and GE--now offer thelower cost technology.
The PETtrace 200 is a dual-particle cyclotron. The advantageof this technology is that two targets can be irradiated at once,producing two different isotopes simultaneously, Wilson said.
"This is beneficial if you have a big program or multiplescanners that you are supporting," he said.
The Scanditronix cyclotron can produce oxygen-15, nitrogen-13,carbon-11 and fluorine-18 PET tracers.
GE's relationship with Scanditronix works well for both sides,Wilson said. The world's largest medical imaging equipment vendorhas no desire to build cyclotrons.
"We want to stick to our knitting," he said. "Weare an image processing and sales and service company. We don'twant to be an accelerator manufacturer. Scanditronix is as goodat that as anyone--maybe better. We want them to stick to theirknitting, so they can engineer and manufacture a state-of-the-artcyclotron, and we can market it for them."
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.